Q32 Bio has a total of 14 patents globally, out of which 2 have been granted. Of these 14 patents, all patents are active. United States of America is where Q32 Bio has filed the maximum number of patents, followed by Saudi Arabia and India. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Q32 Bio.
Q32 Bio was founded in the year 2017. The Company operates as a biotech company. The Company develops and discovers treatments for restoring immune homeostasis in patients with severe inflammatory and autoimmune diseases.
Do read about some of the most popular patents of Q32 Bio which have been covered by us in this article and also you can find Q32 Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Q32 Bio patent portfolio.
How many patents does the founder and the CEO of Q32 Bio have?
The founder Shelia Violette has 0 patent and CEO Jodie Morrison has 0 patent.
How many patents does Q32 Bio have?
Q32 Bio has a total of 14 patents globally. These patents belong to 2 unique patent families. Out of 14 patents, all patents are active.
How Many Patents did Q32 Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Q32 Bio Applications Filed | Q32 Bio Patents Granted |
2022 | 1 | – |
2021 | 7 | 2 |
2020 | 2 | – |
2019 | 4 | – |
How many Q32 Bio patents are Alive/Dead?
All the patents were filed by Q32 Bio are Alive.
How Many Patents did Q32 Bio File in Different Countries?
Countries in which Q32 Bio Filed Patents
Country | Patents |
United States Of America | 3 |
Saudi Arabia | 1 |
India | 1 |
South Africa | 1 |
Europe | 1 |
Mexico | 1 |
Hong Kong (S.A.R.) | 1 |
Canada | 1 |
Singapore | 1 |
Indonesia | 1 |
Australia | 1 |
Israel | 1 |
Where are Research Centres of Q32 Bio Patents Located?
What Percentage of Q32 Bio US Patent Applications were Granted?
Q32 Bio (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Q32 Bio patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Q32 Bio?
Law Firm | Total Applications | Success Rate |
Mccarter & English Llp Boston | 3 | 100.00% |
List of Q32 Bio Patents
Q32 Bio Patents | Title |
US11053305B2 | Fusion Protein Constructs Comprising Anti-C3D Antibody And Cr1 Polypeptide |
US11053306B2 | Fusion Protein Constructs Comprising Anti-C3D Antibody And Factor H |
US20210309728A1 | Fusion Protein Constructs For Complement Associated Disease |
EP3893916A4 | Fusion Protein Constructs For Complement Associated Disease |
AU2019398214A1 | Fusion Protein Constructs For Complement Associated Disease |
CA3123004A1 | Fusion Protein Constructs For Complement Associated Disease |
SA521422244A | Fusion Protein Constructs For The Treatment Of Complement-Related Disease |
HK40061382A | Fusion Protein Constructs For Complement Associated Disease |
IN202117031227A | Fusion Protein Constructs For Complement Associated Disease |
MX2021006930A | Fusion Protein Constructs For Complement Associated Disease. |
ID2021PID07549A | Array Of Fusion Proteins For Complement Related Diseases |
SG11202106073QA | Fusion Protein Constructs For Complement Associated Disease |
IL283841A | Fusion Protein Constructs For Complement Associated Disease |
ZA202104008A | Fusion Protein Constructs For Complement Associated Disease |
What are Q32 Bio key innovation segments?
What Technologies are Covered by Q32 Bio?
The chart below distributes patents filed by Q32 Bio